approval
saveVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approval
community read0 votes
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalSep 22, 2021 · 1839d ago
- approvalVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalJan 14, 2021 · 2090d ago
- approvalVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalSep 23, 2019 · 2569d ago
- approvalVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalApr 24, 2015 · 4182d ago
- approvalVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalAug 5, 2014 · 4444d ago
- approvalVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalMay 7, 2013 · 4899d ago
- approvalVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalJan 23, 2012 · 5369d ago
- approvalVINCRISTINE SULFATE PFS (VINCRISTINE SULFATE) — FDA approvalJan 25, 2007 · 7193d ago
same company · ±60 days · 6
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalBUTORPHANOL TARTRATE: BUTORPHANOL TARTRATE PRESERVATIVE FREE (BUTORPHANOL TARTRATE) — FDA approvalDec 22, 2025
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalBUPRENORPHINE HYDROCHLORIDE: BUPRENORPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalHYDROMORPHONE HYDROCHLORIDE: HYDROMORPHONE HYDROCHLORIDE — FDA approvalDec 22, 2025
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025
comments(0)
5-min edit window · permanent after that